Glucocorticoids Alter the Balance Between Pro- and Anti-inflammatory Mediators in the Myocardium in a Porcine Model of Brain Death

Journal of Heart and Lung Transplantation

Volumn 26, Issue 1, 2007, Pages 78-84

  McLean, Kelly M ^a,b   Duffy, Jodie Y ^a,b   Pandalai, Prakash K ^b   Lyons, Jefferson M ^a,b   Bulcao, Christian F ^b   Wagner, Connie J ^a   Akhter, Shahab A ^b   Pearl, Jeffrey M ^a,b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; BETA ADRENERGIC RECEPTOR; GLUCOCORTICOID; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 6; METHYLPREDNISOLONE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DEATH; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; HEART FUNCTION; HEART LEFT VENTRICLE; HEART TRANSPLANTATION; HOMOGENATE; MEDIATOR RELEASE; NONHUMAN; ORGAN DONOR; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SIGNAL TRANSDUCTION; SWINE;

ANIMALS; BRAIN DEATH; DISEASE MODELS, ANIMAL; GLUCOCORTICOIDS; HEART VENTRICLES; I-KAPPA B PROTEINS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-10; INTERLEUKIN-6; MYOCARDIUM; NF-KAPPA B; SWINE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33846211540     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2006.10.011     Document Type: Article

References (58)

1. Wilhelm M.J., Pratschke J., Laskowski I.A., Paz D.M., and Tilney N.L. Brain death and its impact on the donor heart-lessons from animal models. J Heart Lung Transplant 19 (2000) 414-418
2. Rosendale J.D., Kauffman H.M., McBride M.A., et al. Hormonal resuscitation yields more transplanted hearts, with improved early function. Transplantation 75 (2003) 1336-1341
3. Taniguchi S., Kitamura S., Kawachi K., Doi Y., and Aoyama N. Effects of hormonal supplements on the maintenance of cardiac function in potential donor patients after cerebral death. Eur J Cardiothorac Surg 6 (1992) 96-102
4. Lyons J.M., Pearl J.M., McLean K.M., et al. Glucocorticoid administration reduces cardiac dysfunction after brain death in pigs. J Heart Lung Transplant 24 (2005) 2249-2254
5. Wilhelm M.J., Pratschke J., Beato F., et al. Activation of the heart by donor brain death accelerates acute rejection after transplantation. Circulation 102 (2000) 2426-2433
6. Birks E.J., Burton P.B.J., Owen V., et al. Elevated tumor necrosis factor-alpha and interleukin-6 in myocardium and serum of malfunctioning donor hearts. Circulation 102 suppl III (2000) III-352-III-358
7. Birks E.J., Owen V.J., Burton P.B.J., et al. Tumor necrosis factor-alpha is expressed in donor heart and predicts right ventricular failure after human heart transplantation. Circulation 102 (2000) 326-331
8. Oral H., Dorn GW I.I., and Mann D.L. Sphingosine mediates the immediate negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian cardiac myocyte. J Biol Chem 272 (1997) 4836-4842
9. Kumar A., Thota V., Dee L., Olson J., Uretz E., and Parrillo J.E. Tumor necrosis factor α and interleukin 1β are responsible for in vitro myocardial cell depression induced by human septic shock serum. J Exp Med 183 (1996) 949-958
10. Meldrum D.R. Tumor necrosis factor in the heart. Am J Physiol Regul Integr Comp Physiol 274 (1998) R577-R595
11. Gulick T., Chung M.K., Pieper S.J., Lange L.G., and Schreiner G.F. Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte beta-adrenergic responsiveness. Proc Natl Acad Sci USA 86 (1989) 6753-6757
12. Wollert K.C., and Drexler H. The role of interleukin-6 in the failing heart. Heart Fail Rev 6 (2001) 95-103
13. Testa M., Yeh M., Lee P., et al. Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension. JAMA 28 (1996) 964-971
14. Hartman J.C., Anderson D.C., Wiltse A.L., et al. Protection of ischemic/reperfused canine myocardium by CL18/6, a monoclonal antibody to adhesion molecule ICAM-1. Cardiovasc Res 30 (1995) 47-54
15. Tanio J.W., Basu C.B., Albelda S.M., and Eisen H.J. Differential expression of the cell adhesion molecules ICAM-1, VCAM-1, and E-selectin in normal posttransplantation myocardium. Cell adhesion molecules in human cardiac allografts. Circulation 89 (1994) 1760-1768
16. Graciano A.L., Bryant D.D., White D.J., Horton J., Bowles N.E., and Giroir B.P. Targeted disruption of ICAM-1, P-selectin genes improves cardiac function and survival in TNF-alpha transgenic mice. Am J Physiol 280 (2001) H1464-H1471
17. de Bosscher K., Berghe W.V., and Haegeman G. The interplay between the glucocorticoid receptor and nuclear factor-(B or activator protein-1: molecular mechanisms for gene repression. Endocrine Rev 24 (2003) 488-522
18. Taniguchi T. Regulation of cytokine gene expression. Annu Rev Immunol 6 (1988) 439-464
19. Pearl J.M., Nelson D.P., Schwartz S.M., et al. Glucocorticoids reduce ischemia-reperfusion-induced myocardial apoptosis in immature hearts. Ann Thorac Surg 74 (2002) 830-837
20. Pearl J.M., Schwartz S.M., Nelson D.P., et al. Preoperative glucocorticoids decrease pulmonary hypertension in piglets after cardiopulmonary bypass and circulatory arrest. Ann Thorac Surg 77 (2004) 994-1000
21. Duffy J.Y., Nelson D.P., Schwartz S.M., et al. Glucocorticoids reduce cardiac dysfunction after cardiopulmonary bypass and circulatory arrest in neonatal piglets. Pediatr Crit Care Med 5 (2004) 28-34
22. Marone G., Lichtenstein L.M., and Plaut M. Hydrocortisone and human lymphocytes: increases in cyclic adenosine 3′:5′-monophosphate and potentiation of adenylate cyclase-activating agents. J Pharmacol Exp Ther 215 (1980) 469-478
23. Lee T.P., and Reed C.E. Effects of steroids on the regulation of the levels of cyclic AMP in human lymphocytes. Biochem Biophys Res Commun 78 (1977) 998-1004
24. Logsdon P.J., Middleton Jr. E., and Coffey R.G. Stimulation of leukocyte adenyl cyclase by hydrocortisone and isoproterenol in asthmatic and non-asthmatic subjects. J Allergy Clin Immunol 50 (1972) 45-56
25. Davies A.O., and Lefkowitz R.J. Agonist-promoted high affinity state of the beta-adrenergic receptor in human neutrophils: modulation by corticosteroids. J Clin Endocrinol Metab 53 (1980) 703-738
26. Davies A.O., and Lefkowitz R.J. Corticosteroid-induced differential regulation of beta-adrenergic receptors in circulating human polymorphonuclear leukocytes and mononuclear leukocytes. J Clin Endocrinol Metab 51 (1980) 599-605
27. D'Amico T.A., Meyers C.H., Koutlas T.C., et al. Desensitization of myocardial beta-adrenergic receptors and deterioration of left ventricular function after brain death. J Thorac Cardiovasc Surg 110 (1995) 746-751
28. White M., Wiechmann R.J., Roden R.L., et al. Cardiac beta-adrenergic neuroeffector systems in acute myocardial dysfunction related to brain injury. Circulation 92 (1995) 2183-2189
29. Pandalai P.K., Lyons J.M., Duffy J.Y., et al. Role of the beta-adrenergic receptor kinase in myocardial dysfunction following brain death. J Thorac Cardiovasc Surg 130 (2005) 1183-1189
30. Brichetto L., Milanese M., Song P., et al. Beclomethasone rapidly ablates allergen-induced beta 2-adrenoceptor pathway dysfunction in human isolated bronchi. Am J Physiol Lung Cell Mol Physiol 284 (2003) L133-L139
31. Askoy M.O., Mardidni I.A., Yang Y., Bin W., Zhou S., and Kelsen S.G. Glucocorticoid effects on the beta-adrenergic receptor-adenylyl cyclase system of human airway epithelium. J Allergy Clin Immunol 109 (2002) 491-497
32. Mak J.C., Hisada T., Salmon M., Barnes P.J., and Chung K.F. Glucocorticoids reverse IL-1beta-induced impairment of beta-adrenoceptor-mediated relaxation and up-regulation of G-protein-coupled receptor kinases. Br J Pharmacol 135 (2002) 987-996
33. Schwartz S.M., Duffy J.Y., Pearl J.M., Goins S., Wagner C.J., and Nelson D.P. Glucocorticoids preserve calpastatin and troponin I during cardiopulmonary bypass in immature pigs. Pediatr Res 54 (2003) 91-97
34. Salomon Y., Londos C., and Rodbell M. A highly sensitive adenylate cyclase assay. Anal Biochem 58 (1974) 541-548
35. Condorelli G., Morisco C., Latronico M.V., et al. TNF signal transduction in rat neonatal cardiac myocytes: definition of pathways generating for the TNF-α receptor. FASEB J 16 (2002) 1732-1737
36. Dinarello C.A., Cannon J.G., Wolff S.M., et al. Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of IL-1. J Exp Med 163 (1986) 1433-1450
37. Jablons D.M., Mulé J.J., McIntosh J.K., et al. IL-6/IFN-β-2 as a circulating hormone. Induction by cytokine administration in humans. J Immunol 142 (1989) 1542-1547
38. Stuhlmeier K.M., Csizmadia V., Cheng Q., Winkler H., and Bach F.H. Selective inhibition of E-selectin, ICAM-1, VCAM in endothelial cells. Eur J Immunol 24 (1994) 2186-2190
39. Yokoyama T., Vaca L., Rossen R.D., Durante W., Hazarika P., and Mann D.L. Cellular basis for the negative inotropic effects of tumor necrosis factor-α in the adult mammalian cardiac myocyte. J Clin Invest 92 (1993) 2303-2312
40. + transients. FEBS Lett 376 (1995) 24-30
41. Hirano T. Interleukin-6 and its relation to inflammation and disease. Clin Immunol Immunopathol 62 suppl (1992) S60-S65
42. Hirano T., Akira S., Taga T., and Kishimoto T. Biological and clinical aspects of interleukin-6. Immunol Today 11 (1990) 443-449
43. Vandenabeele P., and Fiers W. Alzheimer's disease due to an IL-1/IL-6 mediated 'acute phase response' in the brain?. Immunol Today 12 (1991) 217-219
44. Hermus A.R., and Sweep C.G. Cytokines and the hypothalamic-pituitary-adrenal axis. J Steroid Biochem Mol Biol 37 (1990) 867-871
45. Finkel M.S., Oddis C.V., Jacob T.D., Watkins S.C., Hattler B.G., and Simmons R.L. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 257 (1992) 387-389
46. Dustin M.L., Rothlein R., Bhan A.K., Dinarello C.A., and Springer T.A. Induction by IL-1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J Immunol 137 (1998) 245-254
47. Kilbridge P.M., Mayer J.E., Newburger J.W., Hickey P.R., Walsh A.Z., and Neufeld E.J. Induction of intercellular adhesion molecule-1 and E-selectin mRNA in heart and skeletal muscle of pediatric patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 107 (1994) 1183-1192
48. Ferrera R., Ovize M., Claustrat B., and Hadour G. Stable myocardial function and endocrine dysfunction during experimental brain death. J Heart Lung Transplant 24 (2005) 921-927
49. Lin T.J., and Befus A.D. Differential regulation of mast cell function by IL-10 and stem cell factor. J Immunol 159 (1997) 4015-4023
50. Arock M., Zuany-Amorim C., Singer M., Benhamou M., and Pretolani M. Interleukin-10 inhibits cytokine generation from mast cells. Eur J Immunol 26 (1996) 166-170
51. Wang P., Wu P., Anthes J.C., Siegel M.I., Egan R.W., and Billah M.M. Interleukin-10 inhibits interleukin-8 production in human neutrophils. Blood 83 (1994) 2678-2683
52. Abu-Amer Y., Ross F.P., McHugh K.P., Livolsi A., Peyron J.F., and Teitelbaum S.L. Tumor necrosis factor-alpha activation of nuclear transcription factor-kappaB in marrow macrophages is mediated by c-Src tyrosine phosphorylation of I kappa B-alpha. J Biol Chem 273 (1998) 29417-29423
53. Funakoshi H., Kubota T., Machida Y., et al. Involvement of inducible nitirc oxide synthase in cardiac dysfunction with tumor necrosis factor-alpha. Am J Physiol Heart Circ Physiol 282 (2002) H2159-H2166
54. +-independent manner in cardiac myocytes: role of troponin I phosphorylation. Biochem Biophys Res Commun 256 (1999) 398-403
55. Long C.S. The role of interleukin-1 in the failing heart. Heart Fail Rev 6 (2001) 81-94
56. Hermoso M.A., and Cidlowski J.A. Putting the brake on inflammatory responses: the role of glucocorticoids. IUBMB Life 55 (2003) 497-504
57. Ungureanu-Longrois D., Balligand J.L., Simmons W.W., et al. Induction of nitric oxide synthase activity by cytokines in ventricular myocytes is necessary but not sufficient to decrease contractile responsiveness to beta-adrenergic agonists. Circ Res 77 (1995) 494-502
58. Shemie S.D., Ross H., Pagliarello J., et al. Organ donor management in Canada: recommendations of the forum on medical management to optimize donor organ potential. CMAJ 174 suppl (2006) S13-S30